Cargando…
Breast cancer research and the European Union Clinical Trials Directive
Running clinical trials in the commercial sector has always been associated with a certain amount of bureaucracy due to the stringent requirements needed to bring a new drug onto the market. Noncommercial trials have largely been performed outside these requirements. New legislation brought about as...
Autor principal: | Williams, Norman |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC468644/ https://www.ncbi.nlm.nih.gov/pubmed/15217484 http://dx.doi.org/10.1186/bcr800 |
Ejemplares similares
-
Responsible decision-making for plant research and breeding innovations in the European Union
por: Eriksson, Dennis, et al.
Publicado: (2017) -
Clinical trials update of the European Organization for Research and Treatment of Cancer Breast Cancer Group
por: Rutgers, Emiel JT, et al.
Publicado: (2004) -
The European Union physical agents (electromagnetic fields) directive: an update for the MRI community
por: Keevil, S F, et al.
Publicado: (2013) -
Approval and Certification of Ophthalmic AI Devices in the European Union
por: Grzybowski, Andrzej, et al.
Publicado: (2023) -
Integration of Translational Research in the European Organization for Research and Treatment of Cancer Research (EORTC) Clinical Trial Cooperative Group Mechanisms
por: Lehmann, Frederic, et al.
Publicado: (2003)